EU OKs wider use of Roche's Avastin

Swiss drugmaker Roche Holding today announced that the EU has permitted the use of its cancer treatment Avastin with other chemotherapy drugs, including its oral treatment Xeloda. The approval covers the drug's use for initial and later treatment in metastatic colorectal cancer patients.

View Full Article in:

Wall Street Journal (free content), The · Guardian (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ